| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 54,080 | 48,906 | 10,669 | 16,387 |
| Prepaid expenses | 864 | 353 | 932 | 1,868 |
| Other current assets | 88 | 2,853 | 2,915 | 2,698 |
| Total current assets | 55,032 | 52,112 | 14,516 | 20,953 |
| Right-of-use assets | 595 | 666 | 735 | 803 |
| Other assets | 539 | 243 | 62 | 64 |
| Total assets | 56,166 | 53,021 | 15,313 | 21,820 |
| Accounts payable | 2,683 | 943 | 1,386 | 807 |
| Accrued expenses and other current liabilities | 8,101 | 9,143 | 7,502 | 6,310 |
| Debt, current portion | 1,000 | 0 | 539 | 943 |
| Total current liabilities | 11,784 | 10,086 | 9,427 | 8,060 |
| Other liabilities | NaN | 0 | 0 | 0 |
| Lease liabilities, net of current portion | 332 | 419 | 500 | 580 |
| Debt, net of current portion | 5,464 | 0 | 0 | 0 |
| Preferred stock-Series ARedeemable Preferred Stock | NaN | NaN | NaN | 0 |
| Warrant liability | 3,938 | NaN | NaN | NaN |
| Preferred stock | NaN | NaN | NaN | 0 |
| Total liabilities | 21,518 | 10,505 | 9,927 | 8,640 |
| Additional paid-in capital | 336,148 | 331,750 | 279,974 | 279,556 |
| Accumulated deficit | -301,500 | -289,234 | -274,588 | -266,376 |
| Total stockholders' equity | 34,648 | 42,516 | 5,386 | 13,180 |
| Total liabilities and stockholders equity | 56,166 | 53,021 | 15,313 | 21,820 |
SPRUCE BIOSCIENCES, INC. (SPRB)
SPRUCE BIOSCIENCES, INC. (SPRB)